Your browser doesn't support javascript.
loading
Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial.
Litwin, Alain H; Lum, Paula J; Taylor, Lynn E; Mehta, Shruti H; Tsui, Judith I; Feinberg, Judith; Kim, Arthur Y; Norton, Brianna L; Heo, Moonseong; Arnsten, Julia; Meissner, Paul; Karasz, Alison; Mckee, M Diane; Ward, John W; Johnson, Nirah; Pericot-Valverde, Irene; Agyemang, Linda; Stein, Ellen S; Thomas, Aurielle; Borsuk, Courtney; Blalock, Kendra L; Wilkinson, Samuel; Wagner, Katherine; Roche, Jillian; Murray-Krezan, Cristina; Anderson, Jessica; Jacobsohn, Vanessa; Luetkemeyer, Anne F; Falade-Nwulia, Oluwaseun; Page, Kimberly.
Afiliación
  • Litwin AH; School of Health Research, Clemson University, Clemson, SC, USA; Department of Medicine, University of South Carolina School of Medicine, Greenville, SC, USA; Department of Medicine, Prisma Health, Greenville, SC, USA. Electronic address: alain.litwin@prismahealth.org.
  • Lum PJ; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Taylor LE; College of Pharmacy, University of Rhode Island, Providence, RI, USA; HIV and Viral Hepatitis Services, CODAC Behavioral Health, Providence, RI, USA.
  • Mehta SH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Tsui JI; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Feinberg J; Department of Behavioral Medicine and Psychiatry, and Department of Medicine, Section of Infectious Diseases, West Virginia University School of Medicine, Morgantown, WV, USA.
  • Kim AY; Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Norton BL; Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, USA.
  • Heo M; Department of Public Health Sciences, Clemson University, Clemson, SC, USA.
  • Arnsten J; Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, USA.
  • Meissner P; Department of Family and Social Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, USA.
  • Karasz A; Department of Family Medicine & Community Health, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Mckee MD; Department of Family Medicine & Community Health, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Ward JW; Coalition for Global Hepatitis Elimination, The Task Force for Global Health, Decatur, GA, USA.
  • Johnson N; New York City Department of Health and Mental Hygiene, New York City, NY, USA.
  • Pericot-Valverde I; Department of Psychology, Clemson University, Clemson, SC, USA; School of Health Research, Clemson University, Clemson, SC, USA.
  • Agyemang L; Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, USA.
  • Stein ES; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Thomas A; College of Pharmacy, University of Rhode Island, Providence, RI, USA.
  • Borsuk C; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Blalock KL; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Wilkinson S; Office of Research Program Management, West Virginia University School of Medicine, Morgantown, WV, USA.
  • Wagner K; University of New Mexico Health Sciences Center, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.
  • Roche J; Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Murray-Krezan C; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Anderson J; University of New Mexico Health Sciences Center, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.
  • Jacobsohn V; Department of Psychiatry and Behavioral Sciences, University of New Mexico, Albuquerque, NM, USA.
  • Luetkemeyer AF; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Falade-Nwulia O; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Page K; University of New Mexico Health Sciences Center, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.
Lancet Gastroenterol Hepatol ; 7(12): 1112-1127, 2022 12.
Article en En | MEDLINE | ID: mdl-36370741
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Abuso de Sustancias por Vía Intravenosa / Hepatitis C / Consumidores de Drogas Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Abuso de Sustancias por Vía Intravenosa / Hepatitis C / Consumidores de Drogas Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article